Company intelligence / Profile preview

iFLYTEK

Ownership: Private
Development stage: Commercial

Overview

iFLYTEK has developed advanced AI-powered speech recognition and natural language processing platforms with broad commercial deployment. In healthcare, its smart medical assistant outperformed most human candidates in China’s national physician exam and provides diagnostic suggestions at scale. The company’s products are widely used in education and healthcare settings across China.

Therapeutic areas: Other
Modalities: DeviceSoftwareArtificial intelligence platform
Industry: Digital Health Medical Devices

Partnerships

University of Science and Technology of China (USTC)Chinese Academy of Social Sciences (CASS)Former partnership with MIT CSAIL lab for AI research

Beyond the preview

Go deeper on iFLYTEK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iFLYTEK.

Explore the full profile